One of the issues raised was the steady decline in reimbursements. Unadjusted and adjusted average reimbursement for GI procedures dropped by 7% and 33%, respectively from 2007 to 2022, according to a ...
Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced ...
Because small numbers of highly cited articles can have outsized influence on certain citation measures like the 2-year Journal Impact Factor (JIF) (see below for definition), Springer Nature ...
Immunic (IMUX) announced that the data from its phase 1/1b clinical trial of IMU-856, an orally available and systemically acting small molecule modulator that targets SIRT6, has been published in the ...
Another "loophole" in colonoscopy reimbursements is the fact that if a colonoscopy becomes diagnostic, patients can expect to pay 15% of the Medicare-approved amount for a physicians' services. In ...
Chatbots based on large language models (LLMs) are rapidly emerging in the field of medicine, extending their applications to gastroenterology and digestive endoscopy. A growing body of evidence is ...